Current and future therapeutic approaches in locally advanced (stage III) non-small cell lung cancer

被引：16

作者：

Davies, A ^{[1
]}

Gandara, DR ^{[1
]}

Lara, P ^{[1
]}

Goldberg, Z ^{[1
]}

Roberts, P ^{[1
]}

Lau, D ^{[1
]}

机构：

[1] Univ Calif Davis, Ctr Canc, Div Hematol Oncol, Sacramento, CA 95817 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期

关键词：

D O I：

10.1053/sonc.2002.34257

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：10 / 16

页数：7

共 33 条

[11] Multimodality therapy in stage III non-small cell lung cancer [J].

Edelman, MJ ;

Gandara, DR ;

Roach, M ;

Benfield, JR .

ANNALS OF THORACIC SURGERY, 1996, 61 (05) :1564-1572

[12] Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens [J].

Fossella, FV ;

DeVore, R ;

Kerr, RN ;

Crawford, J ;

Natale, RR ;

Dunphy, F ;

Kalman, L ;

Miller, V ;

Lee, JS ;

Moore, M ;

Gandara, D ;

Karp, D ;

Vokes, E ;

Kris, M ;

Kim, Y ;

Gamza, F ;

Hammershaimb, L .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) :2354-2362

[13] Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer [J].

Furuse, K ;

Fukuoka, M ;

Kawahara, M ;

Nishikawa, H ;

Takada, Y ;

Kudoh, S ;

Katagami, N ;

Ariyoshi, Y .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2692-2699

[14]

Gandara DR, 2001, ANTI-CANCER DRUG, V12, pS5

[15]

GASPAR L, 2001, P AM SOC CLIN ONCOL, V20, pR20

[16]

GOLDBERG Z, 2001, PRINC PRACT, V1, P1

[17] Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: A California Cancer Consortium phase II trial [J].

Lau, D ;

Leigh, B ;

Gandara, D ;

Edelman, M ;

Morgan, R ;

Israel, V ;

Lara, P ;

Wilder, R ;

Ryu, J ;

Doroshow, J .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) :442-447

[18] Southwest oncology group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer [J].

Lau, DH ;

Crowley, JJ ;

Hazuka, MB ;

Albain, KS ;

Leigh, B ;

Fletcher, WS ;

Lanier, KS ;

Keiser, WL ;

Livingston, RB .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (09) :3078-3081

[19] RADIOTHERAPY ALONE VERSUS COMBINED CHEMOTHERAPY AND RADIOTHERAPY IN NONRESECTABLE NON-SMALL-CELL LUNG-CANCER - 1ST ANALYSIS OF A RANDOMIZED TRIAL IN 353 PATIENTS [J].

LECHEVALIER, T ;

ARRIAGADA, R ;

QUOIX, E ;

RUFFIE, P ;

MARTIN, M ;

TARAYRE, M ;

LACOMBETERRIER, MJ ;

DOUILLARD, JY ;

LAPLANCHE, A .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (06) :417-423

[20]

Pritchard RS, 1996, ANN INTERN MED, V125, P723, DOI 10.7326/0003-4819-125-9-199611010-00003

← 1 2 3 4 →